Navigation Links
Osiris in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes

JDRF Partners with Osiris on a Phase II Trial to Evaluate an Immunomodulatory Cell Therapy Product For Type 1 Diabetes New York, NY October 25, 2007 The Juvenile Diabetes Research Foundation announced today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support a Phase II cli...

Biotech Osiris to go public

Baltimore biotech, the company that is known for being the sole manufacturer of the stem cell product, has made its plans known, about its intention to go public//. The company is slated to sell out nearly $80 million in shares, as per the papers filed with the Securities and Exchange Commission. ...

Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility

...Vasive has accelerated the transfer of the processing of Osteocel Plus from osiris Therapeutics (Nasdaq: OSIR ) to its own exclusive supply chain. Sin...and consistent stream of supply. NuVasive will not assume ownership of the osiris tissue processing facility. NuVasive reiterates its previous guidance ...

Ongoing worldwide shortage of medical isotopes could threaten patient care, says expert

...ld's Mo-99 is produced by five commercial nuclear reactors NRU at Chalk River in Canada, HFR at Petten in The Netherland, BR-2 at Fleurus in Belgium, osiris at Saclay in France and SAFARI-1 at Pelindaba in South Africa. The UK has no facility for producing Mo-99 of its own. Until fairly recently, productio...

BullMarket.com Examines Stem Cell Stocks

...ibers with coverage of stem cell stocks, including Geron (Nasdaq: GERN ), osiris Therapeutics (Nasdaq: OSIR ), Cytori Therapeutics (Nasdaq: CYTX ), and ...ptions surrounding stem cell stocks? -- What are some of the positives osiris has going for it? -- What potential problem could Cytori run into? ...

NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results

...nge of $345 million to $350 million. Osteocel revenue in the fourth quarter 2008 included approximately $5 million in sales to former distributors of osiris Therapeutics, Inc. (Nasdaq: OSIR ). As the Company launches the Osteocel product through its exclusive sales force, it will not have the benefit of...

QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President

...o joining QRxPharma, Soriano was Senior Director of Business Development at osiris Therapeutics, Inc., and responsible for all business development activities... out-licensing and divestiture. During Dr. Soriano's tenure, Maryland-based osiris Therapeutics formed a $1.4 billion partnership with Genzyme Corp. for the d...

Stem Cell Product Commercialization Focus of Summit

...Inc. Novocell, Inc. ArunA Biomedical, Inc. NuVasive, Inc. BioE Corp. osiris Therapeutics, Inc. California Stem Cell, Inc. Progenitor Cell Therapy, Inc. Cellerix, S.A. SpineSmit...

Preliminary Lineup Set for 4th Annual Stem Cell Summit

... Arteriocyte, Inc. Novocell, Inc. BioE Corp. NuVasive, Inc. California Stem Cell, Inc. osiris Therapeutics, Inc. Cellerix, S.A. Progenitor Cell Therapy, Inc. Cognate BioServices, Inc. Stemagen Cytori Ther...
Osiris in Medical Technology

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...ceuticals, Genzyme Biosurgery, Integra LifeSciences, LifeNet Health, Medtronic Spinal and Biologics, Musculoskeletal Transplant Foundation, Orthovita, osiris Therapeutics, Osteotech, RTI Biologics, sanofi-aventis, Smith & Nephew, Stryker, Synthes, Wright Medical Technology, and many more. Other reports ...

Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function

...dical Center, we were able to conduct a study that was exceptionally well planned and executed” said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. “We were confident in the safety profile given our previous experience using the intravenous form of these stem cells to treat oth...
Osiris in Medical Products

Osiris

Description:... osiris is a system built around data management software and an imaging device that measures the inhibition zone size around an antibiotic disc. osiris offers built-in expertise for detection of potential errors and detection o...
Company:Bio-Rad Laboratories
Osiris in Biological News

Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients

...em cells pre-formulated for intravenous delivery by the drug's manufacture, osiris Therapeutics. Patients were administered an infusion of either Provacel or...well planned and executed" said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. "We were confident in the safety profile given our previous e...
Osiris in Biological Technology

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

- Expands biologics platform for robust growth - - Includes proprietary adult stem cell bone graft product and processing facility - - Expects Osteocel(R) revenues of $15 million in 2008 and $25 million in 2009; no dilution to earnings per share in...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

...tal Partners, a Pan-Asian private equity firm with deep connections across Asia, declared, "I believe investors are beginning to see that, compared to osiris -- which is the largest stem cell company with a market cap of around $425 million -- NBS is dramatically undervalued given its IP portfolio, product ...

AssureRx Adds New CEO

... the buyout of a New York Stock Exchange company to form MedPointe Pharmaceuticals. Mr. Burns was also a founder, chairman, president and CEO of osiris Therapeutics Inc., a public biotech company developing therapeutic stem-cell products for the regeneration of damaged or diseased tissues. Previously,...

Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

...o or animal. MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle. Prochymal(R) is a product of osiris Therapeutics, Inc. "There's a lot of enthusiasm in the cardiovascular community about the potential of stem cell therapies for treating heart dis...

Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards

... Best New Product or Progress: C. Randal Mills, Ph.D., president and CEO, osiris Therapeutics, Inc. Mills' Columbia-based company has spent more than $300 million developing stem cell therapies. The funding has allowed osiris to complete clinical trials necessary to demonstrate the safety and efficac...

Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12

...agement Corporation Fred E. Festa , chairman, president and CEO, W.R. Grace & Company Dr. C. Randal Mills , president and CEO, osiris Therapeutics, Inc. Dr. Bruce Thompson , chairman of the board and president, Clinical Trials and Surveys Corp. (C-TASC) Lea...

NuVasive Completes Acquisition of Osteocel Biologics Business

... surgical treatments for the spine, announced today that it has completed the previously announced acquisition of the Osteocel biologics business from osiris Therapeutics, Inc. (Nasdaq: OSIR ) for $35 million in cash, plus additional milestone-based contingent payments not to exceed $50 million in either c...

BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals

... biologists, chemists and many others attended to interview with some of the top biotechnology companies and pharmaceutical firms. Companies including osiris Therapeutics and SAIC-Frederick were hiring for biotech business development careers, pharmaceutical facility management jobs, cell biology careers, b...

Stem Cell Therapy to Skyrocket by 2017

...dvanced Cell Technologies, Arteriocyte, Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies, International Stem Cell Corporation, and osiris Therapeutics. About Stem Cells Stem cells are primal cells that are derived from highly proliferative tissues. These cells are precursors to every o...
Other Tags
(Date:7/25/2014)... 25, 2014 Eye & Vision has ... their office location by expanding a new specialized ocular ... comprehensive visual electro-physiology clinic. , By acquiring specialized Visual ... experience in vision problems, patients with vision loss in ... advantage of the implementation of this specialized vision testing ...
(Date:7/25/2014)... The European liquid chromatography reagents report defines and ... forecast of revenue. The liquid chromatography reagents market in ... and is estimated to grow to around $1581.8 million ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. This also provides ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Twins, genes ... their environment, according to a new study. ... vocabulary, putting words together and grammar, were largely inherited. ... that the "twinning effect" (a lower level of language ... identical twins than non-identical twins. "This finding disputes ...
(Date:7/25/2014)... -- A protein that controls when genes are switched ... areas of the brain to regulate metabolism, UT Southwestern ... lead to new therapies to treat obesity and diabetes, ... protein 1 (Xbp1s) appears to influence the body,s ... are hormones central to the body,s regulation of food ...
(Date:7/25/2014)... 2014 The American Brain Tumor Association ... Development Trainer of Distinguished Events, and Corporate and Special ... Cancer Society, will be joining the ABTA in the ... will oversee the roll out of a nationwide brain ... The recently launched volunteer network will provide the Chicago-based ...
Breaking Medicine News(10 mins):Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 2Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Genes May Be Key to Language Delay in Kids 2Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2
(Date:7/24/2014)... NY (July 24, 2014) Scientists at The ... are one step closer to creating a viable ... patient,s own cells. , For the first ... cells lines from skin samples of patients with ... an accelerated protocol to induce these stem cells ...
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... planet,s current biodiversity, the product of 3.5 billion years ... the history of life. But it may be reaching ... scientific literature and analysis of data published in ... the loss and decline of animals is contributing to ... planet,s sixth mass biological extinction event. , Since 1500, ...
Breaking Biology News(10 mins):NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3
Other Contents